VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
RTO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
RTORentokil Initial plc
$28.78$14.5B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksRTOFinancials

Rentokil Initial plc (RTO) Financials

30Y historyFree accessUpdated daily

Revenue growth has turned volatile with a -4.0% contraction in 2025Q4, while operating margins remain constrained at 13.9%, indicating a failure to achieve meaningful scale-based efficiencies.

RTO Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Sales/Revenue5.14B5.44B5.38B3.71B2.95B2.79B2.68B2.47B2.41B2.17B1.76B1.74B2.33B2.55B2.54B2.5B2.53B2.41B2.2B1.84B1.89B2.18B2.37B2.23B2.14B2.55B2.96B2.88B2.81B2.27B
Revenue Growth %-5.47%1.13%44.72%25.73%5.9%4.23%8.25%2.49%11.26%23.26%1.05%-25.19%-8.61%0.08%1.91%-1.36%5.02%9.37%19.54%-2.23%-13.58%-7.81%5.96%4.17%-15.76%-14.11%2.94%2.36%23.9%164.92%
Cost of Goods Sold4.44B4.71B927M2.74B2.24B2.14B2.1B514.2M474.9M376.1M310.2M297.5M277.2M0000000001.86B1.75B1.67B2.05B2.33B2.29B00
COGS % of Revenue86.32%86.64%17.25%73.69%75.8%76.59%78.43%20.8%19.69%17.35%17.64%17.09%11.91%---------78.66%78.21%77.67%80.46%78.58%79.54%--
Gross Profit702.98M726M4.45B977M714.8M653M577.2M1.96B1.94B1.79B1.45B1.44B2.05B2.55B2.54B2.5B2.53B2.41B2.2B1.84B1.89B2.18B505M486.6M478.8M497.2M634.6M589M2.81B2.27B
Gross Margin %13.68%13.36%82.75%26.31%24.2%23.41%21.57%79.2%80.31%82.65%82.36%82.91%88.09%100%100%100%100%100%100%100%100%100%21.34%21.79%22.33%19.54%21.42%20.46%100%100%
Gross Profit Growth %-3.17%-83.68%355.27%36.68%9.46%13.13%-70.52%1.07%8.11%23.69%0.38%-29.59%-19.5%0.08%1.91%-1.36%5.02%9.37%19.54%-2.23%-13.58%331.96%3.78%1.63%-3.7%-21.65%7.74%-79.05%23.9%164.92%
Operating Expenses0177M3.82B479M348.6M352M322.5M2.03B1.18B1.54B1.25B1.24B2.16B2.4B2.41B2.33B2.4B2.31B2.01B1.65B1.59B1.89B1.9B1.79B50.1M97.2M198M95.7M2.38B1.92B
OpEx % of Revenue-3.26%71.13%12.9%11.8%12.62%12.05%81.98%49%71.24%71.12%71.02%92.64%94.27%94.6%93.32%94.91%95.88%91.08%89.37%84.51%86.63%80.21%80.37%2.34%3.82%6.68%3.32%84.69%84.68%
Selling, General & Admin002.87B479M348.6M352M322.5M1.36B1.33B1.2B965.7M935.7M3.3M00000000000000000
SG&A % of Revenue--53.4%12.9%11.8%12.62%12.05%55.17%55.12%55.24%54.9%53.75%0.14%-----------------
Research & Development07M05M5M0000001.6M1.8M02M1.9M1.7M1.7M1.7M2.8M3M2.9M00000000
R&D % of Revenue-0.13%-0.13%0.17%------0.09%0.08%-0.08%0.08%0.07%0.07%0.08%0.15%0.16%0.13%--------
Other Operating Expenses0170M953M-5M-5M007M10.6M68.7M02.5M1.5M2.4B-8.6M-8.2M-6.6M-5.2M-4M-4M-4.4M-3.6M39.8M44.5M50.1M37.1M198M95.7M2.38B-8M
Operating Income702.98M549M625M317M347M294M254.7M283.1M315.5M257.3M216.8M215.8M171.3M145.8M-10.2M61.5M119.3M82.1M211.9M214.5M270.1M308.5M451.9M438.4M433.1M394.9M437.5M504.7M438.8M339M
Operating Margin %13.68%10.1%11.63%8.54%11.75%10.54%9.52%11.45%13.08%11.87%12.33%12.4%7.36%5.73%-0.4%2.46%4.71%3.41%9.62%11.64%14.33%14.14%19.1%19.63%20.2%15.52%14.76%17.53%15.6%14.94%
Operating Income Growth %28.05%-12.16%97.16%-8.65%18.03%15.43%-10.03%-10.27%22.62%18.68%0.46%25.98%17.49%1529.41%-116.59%-48.45%45.31%-61.26%-1.21%-20.59%-12.45%-31.73%3.08%1.22%9.67%-9.74%-13.31%15.02%29.44%62.98%
EBITDA1.12B869M1.1B575M549M508M580.6M513.3M514.3M501.6M408.7M410.4M403.5M374.1M390.7M427.1M396.5M338.4M409.1M404.1M465.1M497.2M608.9M590.8M577.7M560M628.8M673.1M589.6M449.7M
EBITDA Margin %21.83%15.99%20.47%15.48%18.59%18.21%21.69%20.76%21.32%23.14%23.23%23.58%17.34%14.69%15.36%17.11%15.67%14.04%18.57%21.92%24.67%22.79%25.73%26.46%26.95%22%21.22%23.38%20.97%19.81%
EBITDA Growth %29.09%-21%91.3%4.74%8.07%-12.5%13.11%-0.19%2.53%22.73%-0.41%1.71%7.86%-4.25%-8.52%7.72%17.17%-17.28%1.24%-13.12%-6.46%-18.34%3.06%2.27%3.16%-10.94%-6.58%14.16%31.11%82.06%
D&A (Non-Cash Add-back)418.81M320M475M258M202M214M325.9M230.2M198.8M244.3M191.9M194.6M232.2M228.3M400.9M365.6M277.2M256.3M197.2M189.6M195M188.7M157M152.4M144.6M165.1M191.3M168.4M150.8M110.7M
EBIT702.98M670M682M490M378M303M393M283.1M315.5M257.3M216.8M215.8M182.5M164.5M59.2M66.4M122.4M112.9M225.2M236.2M292M321.1M498.3M491.9M492.8M460.6M580.9M533.3M473.4M361.7M
Net Interest Income-21.57M-156M-164M-72M-33M-34M-44.6M-38M-35.3M-30.8M-33.2M-42.3M-54.6M-40.6M-45.4M-48.5M-46.6M-54.2M-67.7M-59M-61.3M-49.5M-47M-51.7M-62.8M-34.7M-10M-18.8M-29.6M-21M
Interest Income23.06M36M25M5M1M6M9.9M45.4M41.8M38.9M38.8M12.8M15.7M72.4M5.9M4.2M11.7M37.5M17M13.8M59.6M61.9M0055.7M24.8M29.8M23.9M26.8M22.7M
Interest Expense44.63M192M189M77M34M40M54.5M35.6M34.8M38.5M38.3M55.1M70.7M109.7M5.5M7.9M14.7M90.1M87M70.8M116.3M115.5M47M51.7M118.5M59.5M39.8M42.7M56.4M43.7M
Other Income/Expense-412.86M-144M-132M-21M-22M-64M57.7M-397.2M398.1M-23.9M-57.8M-38.9M-48.3M-66.4M-40.3M-47M-54.3M-59.3M-69.9M-49.1M-52.7M-51.8M-55.4M-48.1M-58.8M6.2M103.6M-14.1M-21.8M-21M
Pretax Income290.12M405M493M296M325M230M323.3M-114.1M713.6M208.5M159M163.2M122.6M82.7M-50.5M14.5M65M22.8M142M165.4M217.4M256.7M396.8M390.3M374.3M401.1M541.1M490.6M417M318M
Pretax Margin %5.65%7.45%9.17%7.97%11%8.25%12.08%-4.62%29.58%9.62%9.04%9.38%5.27%3.25%-1.98%0.58%2.57%0.95%6.44%8.97%11.53%11.77%16.77%17.48%17.46%15.76%18.26%17.04%14.83%14.01%
Income Tax74.39M98M112M64M61.9M44M54.7M-15.8M30.6M40.7M34.7M37.1M31.4M29M16.6M34.8M16.1M6.4M30.3M33.3M59.4M69.8M105.2M104.6M108.2M114.3M154.5M139.8M121.4M97.9M
Effective Tax Rate %25.64%24.2%22.72%21.62%19.05%19.13%16.92%13.85%4.29%19.52%21.82%22.73%25.61%35.07%-32.87%240%24.77%28.07%21.34%20.13%27.32%27.19%26.51%26.8%28.91%28.5%28.55%28.5%29.11%30.79%
Net Income349.63M307M381M232M263M186M283.8M-98.3M682.8M167.5M124.3M126.1M37.5M51.4M-69.7M-23.4M47.6M18.8M656.3M245.1M321.5M190.4M290.1M284.6M265.2M285.6M385.3M349.6M294.6M219.2M
Net Margin %6.8%5.65%7.09%6.25%8.9%6.67%10.6%-3.98%28.3%7.73%7.07%7.24%1.61%2.02%-2.74%-0.94%1.88%0.78%29.79%13.3%17.05%8.73%12.26%12.74%12.37%11.22%13%12.15%10.48%9.66%
Net Income Growth %13.89%-19.42%64.22%-11.79%41.4%-34.46%388.71%-114.4%307.64%34.75%-1.43%236.27%-27.04%173.74%-197.86%-149.16%153.19%-97.14%167.77%-23.76%68.86%-34.37%1.93%7.32%-7.14%-25.88%10.21%18.67%34.4%57.36%
Net Income (Continuing)215.73M307M381M232M263M186M283.8M-98.3M683M167.8M124.3M126.1M83.3M73.6M-67.1M-20.3M48.9M16.4M111.7M132.1M158M186.9M291.6M285.7M266.1M286.8M386.6M350.8M295.6M220.1M
Discontinued Operations133.9M00000000000000000000000000000
Minority Interest-1.48M-1M-1M-1M-500K900K600K400K300K100K-200K-200K100K6.7M5.5M10.5M9.3M9M7.4M6.4M7M10.1M6.5M6.3M5.6M5.5M4.9M4.6M3.8M2.4M
EPS (Diluted)0.700.600.750.600.700.500.75-0.271.850.460.340.700.100.14-0.19-0.060.130.051.800.700.900.550.800.750.650.600.650.600.500.43
EPS Growth %16.67%-20%25%-14.29%40%-33.33%377.78%-114.59%302.17%35.29%-51.43%600%-28.57%173.68%-194.57%-149.62%150%-97.11%157.14%-22.22%63.64%-31.25%6.67%15.38%8.33%-7.69%8.33%20%16.28%22.86%
EPS (Basic)0.700.600.750.600.700.500.75-0.271.850.460.340.700.100.14-0.19-0.060.130.051.800.700.900.550.800.750.650.600.700.600.500.43
Diluted Shares Outstanding507M505.6M505.4M402.8M373.26M372.58M372.1M368.24M370.1M368.58M365.34M363.92M364.62M364.42M362.6M361.48M362.06M361.48M361.44M361.3M360.96M361.56M366.98M382.01M400.1M488.44M573.82M574.7M572.64M511.88M
Basic Shares Outstanding504.8M505.77M503.2M400.4M371.62M370.64M369.8M367.48M366.96M365.2M363.84M363.42M363.42M363.38M362.6M361.48M361.48M361.48M361.44M361.3M360.74M361.56M366.52M382.01M398.74M487.86M571.94M572.08M571.26M511.88M
Dividend Payout Ratio64.68%74.59%52.76%52.59%52.85%-30.23%-9.42%33.13%39.34%34.26%102.93%70.43%---567.55%20.33%54.39%38.79%59.61%35.99%34.33%------

Key Metrics

Growth RegimeMixed
ProfitabilityStrained
Balance SheetHealthy
Cash FlowStable
Top Statement Risk

Integration and margin execution

Revenue Growth Facing Integration Headwinds

As reported in recent financial statements, Rentokil's revenue growth has turned volatile, culminating in a -4.0% contraction in 2025Q4, which suggests that the aggressive inorganic expansion strategy is currently struggling to deliver consistent organic momentum following the integration of large-scale North American acquisitions like Terminix.

The shift from high double-digit growth in previous periods to recent contraction indicates that the company may be experiencing friction in its cross-selling efforts. Investors should monitor whether this decline reflects a normalization of post-pandemic demand or a fundamental inability to scale the combined entity's revenue base effectively.

Structural Margin Compression Remains Evident

Based on the provided income statement data, Rentokil's gross margins have consistently hovered in the low-to-mid teens, with the 13.9% margin reported in 2025Q4 highlighting a significant structural disadvantage compared to pure-play pest control competitors like Rollins, which maintain margins near 50%.

This persistent margin profile suggests that the company's service delivery model is highly labor-intensive and potentially burdened by the costs of integrating disparate service lines. The lack of meaningful margin expansion despite significant scale implies that the company may lack the pricing power necessary to offset rising frontline labor costs.

Operating Leverage Scaling Remains Elusive

According to the historical income statement data, Rentokil's operating margins have frequently tracked in lockstep with gross margins, such as the 13.9% parity observed in 2025Q4, which indicates a failure to achieve meaningful operating leverage as the business scales its North American footprint.

The absence of a widening gap between gross and operating margins suggests that SG&A expenses are rising proportionally with revenue, potentially due to the complexity of managing a multi-service, multi-regional organization. This trend warrants further investigation into whether the company's administrative overhead is becoming bloated post-acquisition.

Integration Risks Cloud Operational Narrative

While management emphasizes the benefits of route density and service bundling, the reported -5.47% YoY revenue decline and the persistent 13.68% operating margin suggest that the company may be facing significant revenue dissynergies and cultural integration friction that could undermine long-term shareholder value creation.

Short-sellers would likely focus on the potential for continued margin compression if the company fails to realize the promised synergies from its recent M&A activity. The reliance on inorganic growth to mask organic stagnation appears to be a primary risk factor that could lead to further valuation multiple contraction.

RTO — Frequently Asked Questions

Quick answers to the most common questions about buying RTO stock.

What was Rentokil Initial plc's (RTO) revenue in 2025?

For fiscal year 2025, Rentokil Initial plc (RTO) reported total revenue of $5.14B. This represents a 126.4% increase compared to $2.27B in 1996.

Is Rentokil Initial plc (RTO) profitable?

Rentokil Initial plc (RTO) is profitable, generating $349.6M in net income for the fiscal year ending 2025 with a net profit margin of 6.8%.

What is Rentokil Initial plc's operating profit margin?

Rentokil Initial plc (RTO) reported an operating income of $703.0M, resulting in an operating profit margin of 13.7%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Rentokil Initial plc's gross profit and gross margin?

Rentokil Initial plc (RTO) generated $703.0M in gross profit for the year, representing a gross profit margin of 13.7%. This demonstrates the company's core pricing power and production efficiency.